Thursday, 19 September 2019
Investorideas.com - Cannabis Stock News: Aura's (CSE:BUZZ) (OTC:LMLLF) Pharmadrug Signs Major Supply Agreement Setting Stage for Brand Launch & Expanded Distribution
Investorideas.com - Cannabis Stock News: Aura's (CSE:BUZZ) (OTC:LMLLF) Pharmadrug Signs Major Supply Agreement Setting Stage for Brand Launch & Expanded Distribution
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Interview with Shay Schnet,CEO and Director, Mark Krytiuk, President and Chairman of Nabis Holdings Inc. (CSE: $NAB.C) (OTC: $NABIF)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Interview
with Shay
Schnet,CEO and Director, Mark Krytiuk,
President and Chairman of Nabis Holdings Inc. (CSE: $NAB.C) (OTC:
$NABIF)
Delta, Kelowna, BC –September 19, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/09191Interview-CSENAB.asp
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts
In
today’s podcast I interview Shay Schnet,
the CEO and Director, as well as Mark Krytiuk,
the President and Chairman of the Board of Nabis
Holdings Inc. (CSE: NAB) (OTC: NABIF), where we discussed the importance of
compliance and EU GMP facilities in the U.S. market as well as the cannabis
industry as a whole.
Shay has over 20 years of business
experience and was most recently a founding partner and Vice President of
Operations at MPX Bioceutical Corporation. Shay spent the last 5 years of his
career focused on the North American cannabis space and helped to build MPX’s
portfolio of international cannabis assets.
Mark is a successful cannabis operator
and was a founding partner of MPX. Mark has over 5 years of experience as the
Vice President of Grow Operations for MPX overseeing the production of medical
marijuana and pharma-grade products across North America.Mark has been directly
involved in the rapid expansion and growth of nine facilities in three
different countries, with budgets up to $30 million.
Both made their names known in the
industry as the co-founders of MPX Bioceutical, one of the largest takeover
offers in U.S. Cannabis to date with the MPX merger with iAnthus for $835M CAD.
When
asked about the importance of vertical integration in the U.S. markets, Mark
commented, “there’s a reason for it, especially in the U.S. You can’t cross
state lines, or import cannabis or export cannabis, so you have to be able to
control everything in that manufacturing process. There are certain states
where there is an abundance of cultivation, and we are able to team up with
cultivators and purchase their product at set rates. You’ll see that in
Washington, California and Oregan where there’s an abundance of cultivation.
Our beliefs are always based around GMP quality and standards and to be able to
bring it to a higher standard than what you currently see in the U.S. Canada,
even though the number of SKUs that are allowed to be released are very
limited, they have set the bar very high with very high standards. If you see
what’s happening in Europe, you have to be EU GMP. Unfortunately, the U.S. has
not caught up to GMP, or almost pharma grade standards.”
When
asked about the companies focus on the U.S. market and how this compared to
other international markets coming online Mark commented, “It is the world’s
largest market. I think all of Australia has about 5,000 patients, compared to
just the state of Michigan which has over
350,000 patients. We still have a strong belief that not only is the U.S.
market the largest in the world, but it still has huge upside potential. It’s
still a market where you can’t cross state lines and you don’t have federal
banking, so there’s still a lot of changes coming to the market. By us thinking
that the standard will come up to be GMP, and everyone will have to come to
that standard at some time, for us we can just go to work immediately.”
Adding
on to that and discussing what makes Nabis stand out in this market, Shay
commented, “What we’re doing different is the GMP. You’re not seeing a lot of
the MSO’s really looking at it. By doing GMP right off the bat, we are helping
create the standards and staying above the regulations, knowing they’re coming.
We really looked at California for inspiration. As soon as they introduced
proper regulations into the market you had about 70% of the products drop off
immediately. Right now you’re just seeing some of the bigger brands come back
online, and some of them died off completely and some survived. We know that
that’s going to carry across the nation and we’re just staying ahead of the
curve.”
When
discussing potential federal legalization in the U.S. and how this may affect
the U.S. cannabis market, Shay commented, “It’s not a beneficial factor (for
MSOs) at this point for federal legalization. Even when legalization comes in,
there will still be some State laws. I think you’re a long away from where
California will allow Washignton product to come in. I think federal
legalization won’t really solve too much at this point. As it becomes more real
you’ll have to focus on the branding and the products.”
Shay
added, “I would definitely agree with what Shay just said. If you’re a
cultivator in Washington and now someone can show up and build a million square
foot mega facility, you’re going to be hard pressed to be able to compete for
price at that point. In saying that we don’t build huge mega facilities, we
build small micro GMP facilities. I would also agree with the fact that whether
it’s federally legal or not, the state will not allow their license to be able
to import from another state. The revenues and the jobs are going to be kept in
that state because you still need to cultivate, process and retail it in that
state.”
Nabis
Holdings Inc. has been active in the last month having announced
the acquisition of a cultivation,
production and fulfillment facility located in Camp Verde, Arizona near
Phoenix, making this the second announced acquisition for Nabis in the state of
Arizona following its definitive agreement to acquire a licensed medical
marijuana business including a Phoenix dispensary.
The company also launched BIS
(Be In Synergy), its new exclusive brand of cannabidiol (“CBD”) product lines
as well as announced
entering into a strategic agreement with CannaKorp, Inc. (“CannaKorp”), a
Massachusetts-based technology start-up company that is simplifying and
improving the experience for herbal vaporization, to be an authorized partner
manufacturing and supplying Wisp Pods to be used in CannaKorp’s innovative Wisp Vaporizing System
(“Wisp”) in the state of Arizona. The Company will supply custom Wisp Pods
branded as BIS, the
Company’s recently launched cannabidiol (“CBD”) brand.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Wednesday, 18 September 2019
#Tech Disruption Driving the #Cannabis Sector: (OTC: $GOHE) (OTC: $TRTC) (TSX: $RIV.TO) (OTC: $CNPOF) (OTCQB: $SING)
#Tech Disruption Driving
the #Cannabis Sector: (OTC: $GOHE) (OTC: $TRTC) (TSX: $RIV.TO) (OTC: $CNPOF) (OTCQB: $SING)
Point Roberts WA,
Delta BC – September 18, 2019 - Investorideas.com, a leading investor news
resource covering tech and cannabis stocks releases a snapshot reporting on
some of the key technology developments impacting the cannabis sector and how
companies are deploying “disruptive” technologies to ensure early mover
advantage.
Since Federal
legalization in Canada, and with new markets opening up every day in either the
US or abroad the cannabis industry has become a magnet for game changing
technology growth-whether looking at production, extraction, online sales
platforms, blockchain technology, packaging and so on, the list is endless.
Looking at the
payment sector, Global Payout Inc. (OTC: GOHE), through its wholly
owned subsidiary MTrac Tech Corporation, has now reached a point where it is
effectively processing tens of millions of dollars in daily transaction volume
across its growing base of clients in the multibillion-dollar cannabis
industry.
Read this in full at https://www.investorideas.com/news/2019/cannabis/09181TechDisruption.asp
As demonstrated in
the Company’s recent Q2 disclosure detailing Company financials, MTrac’s growth
trajectory has remained positive and has continued to gain significant traction
throughout the year. This growth can be attributed to the successful
strengthening of their foothold and market reach in what has become one of the
most dynamic industries in today’s economy. This feat has been accomplished in
part through MTrac’s success in securing several strategic service agreements with
some of the largest companies in the industry today.
This follows on the
heels of the launch of MTrac’s massive update to its blockchain
powered payment platform, which includes the addition of new banking partners
to provide a suite of enhancements to improve the merchant experience through
added stability, reliability and system integrity.
Many companies have
attempted to solve the cash problem in cannabis and they most certainly have
all come to realize the complexities of navigating the financial and regulatory
challenges in this constantly evolving industry. The Schedule 1 classification
persists as the main deterrent to financial institutions providing its services
to cannabis merchants.
“We continue to
attract key banking partners with our compliant and seamless solution as an
industry leader in this innovative financial technology space,” said Mr. Kevin
Curtis, MTrac Chief Strategy Officer. “These strategic updates to the MTrac
platform are being done in order to further stabilize the platform and to
continue serving our clients in this next growth phase we are embarking upon.
The MTrac 3.0 launch is the culmination of key partnerships, significant market
share, and our team’s focus on compliance, service, and stability.”
“As these new bank
networks are being injected, MTrac is also downsizing the equipment needed to
process transactions on the merchant side, which will reduce hardware costs and
deployment time to the merchant to enable faster adoption, onboarding, and an
improved checkout process for the customer,” said David Flores, EVP. “These
updates will also provide unlimited processing bandwidth and more secure
transactions with EMV chip and pin debit features, which will allow for overall
enhanced merchant and consumer experience.”
The company has
recently signed a new account application with an anticipated 34 locations and
has applications coming in weekly for the services offered through MTrac.
In addition to their
expanding market reach, the Company is also fully engaged with key legislative
partners in different states to help push for the adoption of their system as a
means of providing merchants within these states with a viable and compliant
payment processing alternative to cash as they remain focused on delivering
“The Key to Cashless®” to as much of this diverse and expanding
industry as possible.
Terra Tech Corp. (OTC: TRTC), has focussed on integrating the best of the
natural world with technology to create sustainable solutions for medical
cannabis production, extraction and distribution, plant science research and
development, food production and Closed Environment Agriculture (CEA).
Through its Blüm
Santa Ana dispensary, Terra Tech has been a major supplier of medical and
adult-use cannabis to Santa Ana and the surrounding cities, such as Irvine,
Laguna Beach and Newport Beach. All of the aforementioned cities suffer from a
scarcity of existing cannabis dispensaries. The launch of their premier
delivery service has enabled the Company to expand distribution of its
best-in-class cannabis products to reach an even greater number of patients and
customers.
Terra Tech purchased
multiple delivery vans and hired sales associates to deliver products within
Orange County, CA, starting with a 20-mile radius out of the Company's Blüm
Santa Ana store.
The company recently entered into an agreement to
sell 100% of the assets of its Blüm Reno dispensary located at 1085 S Virginia
St Suite A, Reno, NV 89502, including the building where the dispensary is
located, for a purchase price of $15,000,000.
Terra Tech’s Blüm
Reno dispensary has been operational since January 2017 and provides cannabis
products to the local medical and adult-use markets, including the Company’s
proprietary IVXX™ brand of premium medical cannabis, flowers, shatters, waxes
and oils, among other high-quality cannabis products from a range of reputable
providers of superior grade medical cannabis.
Derek Peterson, CEO
of Terra Tech, commented, ''Selling the cannabis retail license for our Blüm
Reno dispensary is another key milestone in our restructuring plan, a strategy
that has been implemented to leverage our balance sheet to fuel growth, as
opposed to approaching the capital markets more often than is necessary. Our
Blüm dispensary in Reno has substantially increased in value since its opening
and selling its assets allows the Company to strategically monetize this asset.
To move forward with our restructuring strategy, we plan to redeploy the
additional capital generated by this sale toward more productive assets in
California in areas such as infrastructure and sales and marketing.”
One company that has
been keeping pace with the advanced technology trends coming to the industry is
Canopy Rivers Inc. (TSX: RIV.TO) (OTC: CNPOF), a venture capital
firm specializing in cannabis. The company recently announced that its portfolio
company, TerrAscend Corp. has entered into a distribution agreement with Syqe
Medical, Ltd., an Israel-based pharma-tech company, to launch Syqe's flagship
product, The Syqe™ Inhaler, in Canada.
The Syqe™ Inhaler is
the world's first metered-dose medical cannabis inhaler and will provide
Canadians with an alternative to dried flower medical cannabis. Metered dosing
allows patients and healthcare providers to predictably, precisely and
consistently deliver treatment at pharmaceutical standards. Syqe's technology
is supported by completed controlled clinical trials, a milestone only a
limited number of companies have achieved, with patients suffering from chronic
pain. The Syqe treatment provides rapid pain relief while reducing psychoactive
effects, allowing patients to resume normal daily activities. The technology
was launched in the Israeli market in June 2019.
"We continue to be
thrilled with the steps TerrAscend is taking to build an industry-leading
business that spans retail, manufacturing, distribution, biotechnology, and now
health tech," said Narbe Alexandrian, President and CEO of Canopy Rivers.
"We believe that TerrAscend is uniquely positioned in the Canadian market
to deliver on the consumer demand for innovative and rigorously tested products
like the Syqe device."
Canopy Rivers is not only looking at production and
consumption technology but also data analytics which is becoming more essential
to the industry. One of their investments, Headset, the leading provider of
data and analytics to the cannabis industry, recently announced it is
launching its competitive intelligence tool, Headset Insights in Canada.
Recreational cannabis has been legal country-wide in Canada since October 2018 and the young and growing market
is still developing. This will be Canada's first retail-derived cannabis market
read based on aggregated Point of Sale data at the receipt-level.
"This announcement is further proof that Headset will
continue to dominate the cannabis data and analytics vertical – first in the United States and now in Canada," said Mr. Alexandrian.
“This announcement validates our belief that in the cannabis industry, like
other mature industries, data will be king."
SinglePoint
Inc. (OTCQB: SING) has also been looking at
disruptive technology coming to the market with their recent shareholder update on the
success of Jacksam/Convectium. As a lead investor in Jacksam before the company
went public, SinglePoint was able to secure sizeable interest in the company.
Jacksam has now gone public and the value of the company has increased
significantly and both parties foresee a very bright future ahead.
“To date, Jacksam has been a tremendous investment for
SinglePoint. This is exactly what we look for when investing or acquiring
businesses. The company was successful in its original vision and has increased
the opportunity for major scalability by opening up the platform. They are now
able to work with some of the biggest companies in the space such a CCELL. We
are excited to be a part of this high growth company and believe it will only
continue its exponential growth,” commented Wil Ralston, President of
SinglePoint.
Convectium is the inventor of the world’s first cannabis
oil filling system and proprietary packaging systems. This is a major
advancement at a time when about 80% of all concentrate products (vapes and
pods) are filled manually. By hand, oil
cartridge fills are completed at a paltry 75 per hour. Convectium’s 710 Shark
system can exceed that in less than a minute on its way to produce between
6,000-12,000 in an hour.
Commenting on their product capabilities,
Jacksam/Convectium CEO, Mark Adams stated: "Up until now companies using
CCell cartridges couldn’t access our state-of-the-art automation equipment
which delivers up to 287% more efficiency and 80% labor savings. Our new 'open
system' approach catapults our market potential to another level by enabling
large-scale CBD or THC concentrate companies to increase output, reduce risks,
costs and waste, and beat the competition. These unique machines enable
concentrate companies to automate the 'fill and cap bottleneck' and cement
Convectium’s position as the only true scalable system in the business.”
While production and cultivation remain essential to the
growth and stability of the cannabis market, we are starting to see how much of
an impact even one of these emerging technologies can have on the ancillary
sectors and how some early adopters have been able to achieve massive
competitive advantages.
For investors
following cannabis stocks, Investor Ideas has created a stock directory of publicly
traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Follow us on Cannabis Social Media
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
Disclosure: this news article featuring GOHE is a paid
for news release on Investorideas.com – third party (two thousand) More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
Get more Marijuana,
hemp & cannabis stock investor ideas-
news, articles, podcasts and stock directories
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...